- Home
- XCUR vs PIII Comparison
XCUR vs PIII Comparison
Compare XCUR & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XCUR
- PIII
- Stock Information
- Founded
- XCUR 2011
- PIII 2015
- Country
- XCUR United States
- PIII United States
- Employees
- XCUR N/A
- PIII 360
- Industry
- XCUR Biotechnology: Pharmaceutical Preparations
- PIII Medical/Nursing Services
- Sector
- XCUR Health Care
- PIII Health Care
- Exchange
- XCUR Nasdaq
- PIII Nasdaq
- Market Cap
- XCUR 29.4M
- PIII 28.9M
- IPO Year
- XCUR N/A
- PIII N/A
- Fundamental
- Price
- XCUR $4.56
- PIII $8.88
- Analyst Decision
- XCUR
- PIII Strong Buy
- Analyst Count
- XCUR 0
- PIII 3
- Target Price
- XCUR N/A
- PIII $17.50
- AVG Volume (30 Days)
- XCUR 39.8K
- PIII 3.3K
- Earning Date
- XCUR 11-13-2025
- PIII 11-14-2025
- Dividend Yield
- XCUR N/A
- PIII N/A
- EPS Growth
- XCUR N/A
- PIII N/A
- EPS
- XCUR N/A
- PIII N/A
- Revenue
- XCUR N/A
- PIII $1,461,823,000.00
- Revenue This Year
- XCUR N/A
- PIII N/A
- Revenue Next Year
- XCUR N/A
- PIII $10.45
- P/E Ratio
- XCUR N/A
- PIII N/A
- Revenue Growth
- XCUR N/A
- PIII 4.20
- 52 Week Low
- XCUR $2.39
- PIII $5.80
- 52 Week High
- XCUR $36.00
- PIII $22.22
- Technical
- Relative Strength Index (RSI)
- XCUR 47.57
- PIII 50.55
- Support Level
- XCUR $4.52
- PIII $8.60
- Resistance Level
- XCUR $5.26
- PIII $8.88
- Average True Range (ATR)
- XCUR 0.49
- PIII 0.31
- MACD
- XCUR 0.01
- PIII -0.06
- Stochastic Oscillator
- XCUR 6.06
- PIII 33.41
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.